Holiday Sale | Save 50%
Holiday Sale | Save 50%
Published

Belgians raise 3 million euros to develop new breast cancer test

Summary by De Tijd
05:58 To identify breast cancer even more accurately, in order to quickly choose the right treatment, that's what Abscint aspires to. The Belgian diagnostics specialist is refuelling 3 million euros for a larger phase 2 trial...
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)